Cardiovascular effects of an immunosuppressive agent cyclosporin A

International Journal of Immunopathology and Pharmacology

Volumn 15, Issue 2, 2002, Pages 75-79

  Sakamoto, Hironosuke ^a   Kurabayashi, M ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Calcineurin; Cardiac hypertrophy; Cardiac myxoma; Cyclosporin A; Cytokine; Diabetes; Hyperlipidemia; Hypertension

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CYCLOSPORIN A; CYTOKINE;

BONE MARROW TRANSPLANTATION; CARDIOVASCULAR EFFECT; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MYXOMA; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; HYPERTENSION; IATROGENIC DISEASE; IMMUNOPATHOLOGY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

EID: 0036289013     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200201500201     Document Type: Review

References (46)

1. Cyclosporine
2. Cyclosporine: A new immunosuppressive agent for organ transplantation
3. Cyclosporine in therapeutic doses increase renal allograft vascular resistance
4. Systemic hypertension after cardiac transplantation: Effect of cyclosporine on the renin-angiotensin system
5. Hypertension in renal transplant recipients
6. Hyperlipidemia after organ transplantation
7. Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes?
8. Post-transplant diabetes mellitus: A retrospective study
9. Diabetes mellitus after renal transplantation in the cyclosporine era: An analysis of risk factors
10. Effects of steroid withdrawal on post-transplant diabetes mellitus in cyclosporine-treated renal transplant recipients
11. Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients
12. Post-transplant diabetes in kidney transplant recipients
13. Prevention of cardiac hypertrophy in mice by calcineurin inhibition
14. Carcineurin inhibitors and cardiac hypertrophy
15. Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin
16. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats
17. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure
18. Calcineurin inhibitors and cardiac hypertrophy
19. Immunosuppressive drugs inhibit the production of interleukin-6 and interleukin-8 in cultured cardiac myxoma cells
20. Acute cyclosporine renal dysfunction reversed by dopamine infusion in health subjects
21. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in enervated kidneys in rats
22. Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A
23. Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells
24. Cyclosporine augments renal but not systemic vascular reactivity
25. Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment
26. Effects of nitric oxide blockage and cyclosporin A on cardiovascular and renal function in normal man
27. Nifedipine is a more effective renal vasodilater than captopril in cyclosporine (CSA) transplant (TX) hypertension
28. Effects of cyclosporine therapy on plasma lipoprotein levels
29. Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients?
30. Cyclosporine inhibits catabolism of low-density lipoproteins in HepG2 cells by 25%
31. Reversal of cyclosporine inhibited low density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
32. Steroid diabetes: A sign of overtreatment with steroids in the renal graft recipient?
33. Advantages of low-dose steroids from the day after renal transplantation
34. Effects of cyclosporine on prednisolone metabolism
35. Synthesis-secretion coupling of insulin: Effect of cyclosporine
36. Long-term effects of cyclosporine A on cultured mouse pancreatic islets
37. Role of cyclosporine A in macromolecular synthesis of beta cells
38. Reversibility of the acute effect of cyclosporine A on pancreatic β cells of Wistar rats
39. Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats
40. Transcription factors of the NFAT family: Regulation and function
41. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
42. Primary tumors of the heart
43. Cardiac myxoma: A review
44. Cardiac myxomas
45. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production
46. Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level